The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trialDouglas L. Boggs, Mohini Ranganathan, Andrew Davies et al.|Psychopharmacology|2018Cited by 235
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From CannabisDeepak Cyril D’Souza, Patrick D. Skosnik, Jose Cortes-Briones et al.|Biological Psychiatry Cognitive Neuroscience and Neuroimaging|2015Cited by 210
Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trialJordan Sloshower, Deepak Cyril D’Souza, Patrick D. Skosnik et al.|Journal of Psychopharmacology|2023Cited by 152
Exploratory Controlled Study of the Migraine-Suppressing Effects of PsilocybinEmmanuelle A. D. Schindler, Deepak Cyril D’Souza, R. Andrew Sewell et al.|Neurotherapeutics|2020Cited by 135